BACKGROUND: Factors affecting innate immunity and acting as inflammatory regulators, such as the nuclear peroxisome proliferator-activated receptors (PPAR) could be crucial in the pathogenesis of necrotizing enterocolitis (NEC). We hypothesized that the PPARγ agonist pioglitazone (PIO) might be effective in preventing the development of NEC and/or reducing its severity. METHODS: We studied preterm rats in which NEC was induced using the hypoxia-hypothermia model. The treatment group (TG; n = 30) received enteral PIO (10 mg/kg/d) for 72 h and the control group (CG; n = 30) did not. Animals were sacrificed 96 h after birth. NEC was diagnosed evaluating histological ileum changes, and mRNA levels of IL-4, IL-12, IL-6, IL-10, INF-γ, and TNF-α cytokines were measured. RESULTS: NEC occurrence was higher in the CG (18/30; 60%) than in the TG (5/30; 16.7%) and was more severe. Proinflammatory IL-12 and INF-γ mRNA levels were significantly lower in the TG than in the CG; conversely, the anti-inflammatory IL-4 mRNA level was significantly higher in the TG than in the CG. CONCLUSION: Our results demonstrate for the first time that PIO is effective in reducing the incidence and severity of NEC and in decreasing renal injuries in a preterm rat model.
BACKGROUND: Factors affecting innate immunity and acting as inflammatory regulators, such as the nuclear peroxisome proliferator-activated receptors (PPAR) could be crucial in the pathogenesis of necrotizing enterocolitis (NEC). We hypothesized that the PPARγ agonist pioglitazone (PIO) might be effective in preventing the development of NEC and/or reducing its severity. METHODS: We studied preterm rats in which NEC was induced using the hypoxia-hypothermia model. The treatment group (TG; n = 30) received enteral PIO (10 mg/kg/d) for 72 h and the control group (CG; n = 30) did not. Animals were sacrificed 96 h after birth. NEC was diagnosed evaluating histological ileum changes, and mRNA levels of IL-4, IL-12, IL-6, IL-10, INF-γ, and TNF-α cytokines were measured. RESULTS: NEC occurrence was higher in the CG (18/30; 60%) than in the TG (5/30; 16.7%) and was more severe. Proinflammatory IL-12 and INF-γ mRNA levels were significantly lower in the TG than in the CG; conversely, the anti-inflammatory IL-4 mRNA level was significantly higher in the TG than in the CG. CONCLUSION: Our results demonstrate for the first time that PIO is effective in reducing the incidence and severity of NEC and in decreasing renal injuries in a preterm rat model.
Authors: Christine F Coursodon-Boyiddle; Chelsea L Snarrenberg; Camille K Adkins-Rieck; Josep Bassaganya-Riera; Raquel Hontecillas; Peter Lawrence; J Thomas Brenna; Zeina E Jouni; Bohuslav Dvorak Journal: Am J Physiol Gastrointest Liver Physiol Date: 2012-07-19 Impact factor: 4.052
Authors: Susan R Hintz; Douglas E Kendrick; Barbara J Stoll; Betty R Vohr; Avroy A Fanaroff; Edward F Donovan; W Kenneth Poole; Martin L Blakely; Linda Wright; Rosemary Higgins Journal: Pediatrics Date: 2005-03 Impact factor: 7.124
Authors: Jeffrey R Singer; Emily G Blosser; Carlene L Zindl; Daniel J Silberger; Sean Conlan; Vincent A Laufer; Daniel DiToro; Clay Deming; Ranjit Kumar; Casey D Morrow; Julia A Segre; Michael J Gray; David A Randolph; Casey T Weaver Journal: Nat Med Date: 2019-11-07 Impact factor: 53.440
Authors: Steven X Cho; Ina Rudloff; Jason C Lao; Merrin A Pang; Rimma Goldberg; Christine B Bui; Catriona A McLean; Magdalena Stock; Tilman E Klassert; Hortense Slevogt; Niamh E Mangan; Wei Cheng; Doris Fischer; Stefan Gfroerer; Manjeet K Sandhu; Devi Ngo; Alexander Bujotzek; Laurent Lariviere; Felix Schumacher; Georg Tiefenthaler; Friederike Beker; Clare Collins; C Omar F Kamlin; Kai König; Atul Malhotra; Kenneth Tan; Christiane Theda; Alex Veldman; Andrew M Ellisdon; James C Whisstock; Philip J Berger; Claudia A Nold-Petry; Marcel F Nold Journal: Nat Commun Date: 2020-11-13 Impact factor: 14.919